SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093341
Filing Date
2024-08-08
Accepted
2024-08-08 07:55:21
Documents
49
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-20240630.htm   iXBRL 10-Q 1323209
2 EX-10.1 wve-ex10_1.htm EX-10.1 88543
3 EX-10.2 wve-ex10_2.htm EX-10.2 82580
4 EX-31.1 wve-ex31_1.htm EX-31.1 15103
5 EX-31.2 wve-ex31_2.htm EX-31.2 15245
6 EX-32 wve-ex32.htm EX-32 10334
7 GRAPHIC img57344106_0.jpg GRAPHIC 50036
8 GRAPHIC img57344106_1.jpg GRAPHIC 72608
  Complete submission text file 0000950170-24-093341.txt   4909251

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT wve-20240630.xsd EX-101.SCH 693558
52 EXTRACTED XBRL INSTANCE DOCUMENT wve-20240630_htm.xml XML 420219
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 241186118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)